Propeller Health (formerly known as Asthmapolis) has announced that the latest version of its inhaler tracking system has received 510(k) clearance from the FDA. The system includes a sensor that snaps onto an MDI and mobile apps that monitor and analyze inhaler use.
According to Propeller, the newly approved system also predicts asthma and COPD exacerbations and provides coaching on disease management and inhaler technique. The new sensor has a battery life of more than 18 months, the company said.
Propeller CEO David Van Sickle explained, “Our goal is to minimize or eliminate exacerbations – that drives everything we do. Key to that, particularly as we move deeper into COPD, is optimizing both the patient and provider experience on Propeller. We are delighted to share this news on World Asthma Day. We remain focused on building ever better tools to passively collect timely data about inhaled medication use, provide people with coaching and guidance that is relevant, personalized, and actionable, and make care teams more efficient through new opportunities to intervene.”
Read the Propeller press release.
